TERT and melanoma: The highest frequencies of TERT promoter mutations have been reported in melanoma, bladder cancer, urothelial carcinoma, CNS tumors, hepatocellular carcinoma, thyroid cancer, basal cell carcinoma, and cutaneous squamous cell carcinoma.